$
1. 60
-0.03
-1.8405%
After Hours
$
+0.06 +3.75% 1. 66
6.72M Market Cap
- P/E Ratio
- Div Yield
33,651 Volume
- Eps
$ 1.63
Previous Close 
Want to track IMNN and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Why Is Imunon (IMNN) Stock Up 259% Today?
Imunon (NASDAQ: IMNN ) stock is rocketing higher on Tuesday as the clinical-stage company releases data from a Phase 2 clinical trial of IMNN-001. This is the company's treatment candidate for patients with advanced ovarian cancer.
Investorplace | 2 years ago
